These guidelines provide guidance for the management of acute myeloid leukaemia in pregnancy. Given the lack of evidence in many areas, it is recognised that any of the recommendations are derived from expert opinion.
The guidance makes recommendations on management according to the stage of pregnancy, discusses the need for a multi-disciplinary approach, provides guidance on chemotherapy and managing its complications.
The guideline makes recommendations on the ongoing management and supportive therapies in managing AML in pregnancy, preparations and management of delivery, post-delivery and neonatal follow up.
Declaration of Interests
The BSH paid the expenses incurred during the writing of this guidance. None of the authors had conflicts of interest to declare. All authors have made a declaration of interests to the BSH and Task Force Chairs which may be viewed on request.